COM:TIVICHEALTH
Tivic Health
- Stock
Last Close
0.25
21/11 21:00
Market Cap
2.16M
Beta: -
Volume Today
492.44K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|
average inventory | 358K - | 335K 6.42% | 646K 92.84% | ||
average payables | 369.50K - | 579.50K 56.83% | 1.06M 82.23% | ||
average receivables | 32.50K - | 51.50K 58.46% | 69.50K 34.95% | ||
book value per share | 0.26 - | -0.13 149.64% | 3.80 3,090.78% | 0.38 90.12% | |
capex per share | -0.00 - | -0.00 - | |||
capex to depreciation | -7.75 - | -0.06 - | |||
capex to operating cash flow | 0.01 - | 0.00 - | |||
capex to revenue | -0.07 - | -0.01 - | |||
cash per share | 0.25 - | 0.11 54.82% | 3.71 3,196.34% | 0.36 90.21% | |
days of inventory on hand | 244.53 - | 81.07 66.85% | 120.92 49.14% | 204.41 69.05% | |
days payables outstanding | 189.96 - | 124.47 34.48% | 222.38 78.66% | 313.36 40.91% | |
days sales outstanding | 11.30 - | 22.07 95.35% | 15.96 27.66% | 17.46 9.34% | |
debt to assets | 0.96 - | 0.05 95.09% | 0.09 92.21% | ||
debt to equity | -1.25 - | 0.05 104.27% | 0.15 173.70% | ||
dividend yield | |||||
earnings yield | -0.00 - | -0.00 1.71% | -0.01 639.15% | -0.02 160.23% | |
enterprise value | 4.81B - | 4.81B 0.06% | 1.34B 72.07% | 616.08M 54.13% | |
enterprise value over ebitda | -1.33K - | -1.51K 13.99% | -246.63 83.69% | -61.01 75.26% | |
ev to operating cash flow | -1.31K - | -1.59K 21.31% | -239.33 84.94% | -69.08 71.14% | |
ev to sales | 11.44K - | 5.59K 51.13% | 1.15K 79.40% | 334.83 70.93% | |
free cash flow per share | -0.40 - | -0.33 18.21% | -1.61 391.73% | -0.92 42.53% | |
free cash flow yield | -0.00 - | -0.00 18.21% | -0.00 557.76% | -0.01 248.38% | |
graham net net | 0.21 - | -0.16 178.97% | 3.28 2,120.97% | 0.18 94.37% | |
graham number | 1.61 - | 1.12 30.15% | 14.42 1,185.55% | 2.97 79.41% | |
income quality | 0.88 - | 0.83 5.98% | 0.66 20.57% | 0.88 33.71% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | |
interest coverage | -8.22 - | -7.57 7.89% | -3.09 59.21% | -5.05M 163,429,001.56% | |
interest debt per share | 0.05 - | 0.20 327.09% | 0.72 254.81% | 0.05 92.44% | |
inventory turnover | 1.49 - | 4.50 201.62% | 3.02 32.95% | 1.79 40.85% | |
invested capital | -1.25 - | 0.05 104.27% | 0.15 173.70% | ||
market cap | 4.81B - | 4.81B 0% | 1.36B 71.81% | 619.07M 54.33% | |
net current asset value | 2.32M - | -1.21M 152.18% | 12.53M 1,134.27% | 3.06M 75.56% | |
net debt to ebitda | 0.64 - | -0.13 120.95% | 2.25 1,785.91% | 0.30 86.87% | |
net income per share | -0.45 - | -0.44 1.71% | -2.43 452.58% | -1.04 57.08% | |
operating cash flow per share | -0.40 - | -0.33 17.52% | -1.61 391.73% | -0.92 42.61% | |
payables turnover | 1.92 - | 2.93 52.62% | 1.64 44.03% | 1.16 29.03% | |
receivables turnover | 32.31 - | 16.54 48.81% | 22.86 38.24% | 20.91 8.55% | |
research and ddevelopement to revenue | 2.36 - | 0.77 67.49% | 0.75 1.73% | 0.94 24.86% | |
return on tangible assets | -1.37 - | -2.66 94.14% | -0.56 78.79% | -1.72 205.19% | |
revenue per share | 0.05 - | 0.09 104.76% | 0.33 259.60% | 0.19 43.01% | |
roe | -1.75 - | 3.46 298.00% | -0.64 118.48% | -2.78 334.58% | |
roic | -1.54 - | -12.29 699.71% | -0.38 96.88% | -2.15 461.45% | |
sales general and administrative to revenue | 2.79 - | 1.18 57.78% | 2.51 113.05% | 3.19 27.11% | |
shareholders equity per share | 0.26 - | -0.13 149.64% | 3.80 3,090.78% | 0.38 90.12% | |
stock based compensation to revenue | 0.02 - | 0.09 280.93% | 0.05 46.10% | 0.22 342.48% | |
tangible asset value | 2.37M - | -1.18M 149.64% | 13.27M 1,227.61% | 3.63M 72.65% | |
tangible book value per share | 0.26 - | -0.13 149.64% | 3.80 3,090.78% | 0.38 90.12% | |
working capital | 2.32M - | 222K 90.44% | 13.07M 5,787.39% | 3.43M 73.77% |
All numbers in (except ratios and percentages)